Opiant Pharmaceuticals, Inc.
NASDAQ: OPNT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Roger Crystal
- Employees
- 37
- Headquarters
- Santa Monica, United States
- IPO year
- 2007
- Market cap
- $108.8M
- Website
- https://www.opiant.com
Loading OPNT…
Loading profile data…Frequently asked questions about OPNT
What does Opiant Pharmaceuticals, Inc. (OPNT) do?
Opiant Pharmaceuticals, Inc. functions as a specialized pharmaceutical enterprise, primarily focused on inventing remedies for both various addictions and drug overdoses. A key product in their current portfolio is NARCAN nasal spray, which provides a critical solution for counteracting opioid overdoses. Their development pipeline is robust, fea...
Where does OPNT trade?
Opiant Pharmaceuticals, Inc. (OPNT) trades on the NASDAQ Capital Market.
What sector is OPNT in?
Opiant Pharmaceuticals, Inc. (OPNT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Opiant Pharmaceuticals, Inc.?
Roger Crystal is the chief executive officer of Opiant Pharmaceuticals, Inc. (OPNT).
Where is Opiant Pharmaceuticals, Inc. headquartered?
Opiant Pharmaceuticals, Inc. is headquartered in United States.
Does OPNT pay a dividend?
Opiant Pharmaceuticals, Inc. (OPNT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did OPNT go public?
Opiant Pharmaceuticals, Inc. (OPNT) completed its initial public offering in 2007.